Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cytogen 356

Known as: CYT 356, CYT-356 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
OBJECTIVES The sites of recurrent carcinoma of the prostate were localized with radiolabeled monoclonal antibody, and these sites… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
  • N. Deb, M. Goris, +6 authors S. Knox
  • Clinical cancer research : an official journal of…
  • 1996
  • Corpus ID: 23105335
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The utility of monoclonal antibody (MAb) imaging for detection of occult recurrent prostate cancer was investigated in 14… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
To evaluate whether In-111 capromab pendetide (an antibody conjugate directed to a glycoprotein found primarily on the cell… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Prostate-specific membrane antigen (PSMA) is a trans-membrane glycoprotein recognized by the murine monoclonal antibody (MAb… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The expression of the prostate-specific membrane antigen (PSMA) glycoprotein recognized by the murine monoclonal antibody (MAb… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
We assessed the safety and ability of the 111indium labeled immunoconjugate 7E11-C5.3-glycyl-tyrosyl-(N,e… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
In an attempt to define the possible role of radioimmunoscintigraphy to assess noninvasively the pelvic lymph nodes, we studied… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
A phase 1 study was conducted with the investigational immunoscintigraphic agent, 111In-CYT-356, a radiolabeled, site-specific… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
In this study, a site-specific immunoconjugate, designated CYT-356, of the prostate-reactive monoclonal antibody 7E11-C5 was… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?